Systematic review and meta-analysis finds that patients using biosimilars have equivalent clinical responses and functional capacity compared with those using reference biologic drugs.
When pharmacy technician Shelley Dellamattia suggests that recent graduates “try different areas within the pharmacy, and take all the learning opportunities offered,” she practises what she preaches.
A new Canadian guideline lays out the optimal strategies for providing injectable opioid agonist treatment with prescription heroin and hydromorphone for people with severe opioid use disorder.
A new Canadian guideline for managing opioid use disorders lays out the optimal strategies for the treatment of opioid addiction, including recommending opioid agonist treatment with buprenorphine–naloxone as the preferred first-line treatment.
